Viewing Study NCT06254066


Ignite Creation Date: 2025-12-24 @ 4:01 PM
Ignite Modification Date: 2025-12-30 @ 5:34 AM
Study NCT ID: NCT06254066
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-02-12
First Post: 2024-02-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Adebrelimab Combined With Fluzoparib in HRD-positive HR +/HER2- Advanced Breast Cancer
Sponsor: Zhejiang Cancer Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Female Breast Cancer Patients View
None Histopathologically Confirmed Advanced HR +/HER2-invasive Breast Cancer View
None HRD Positive Advanced Breast Cancer View
Keywords: